Sort by 'shares'
Multiple Myeloma: An Insight into Early Intervention and Personalized Therapies
Myeloma patients are definitely living longer. A decade ago the median survival was 3 to 4 years, while now it is in the range of 8 to 10 years. With all the new drugs and treatments that have been approved,…
Beating Leukemia with Groundbreaking CAR-T Cell Therapy
Dr. Stephan A. Grupp made history when he treated the first child with CAR T cell therapy, Emily Whitehead, who is now more than five years cancer-free. In CAR-T cell therapy, a patient's own genetically altered immune cells fight cancer.…
Endometriosis – The How & Why and Recent Advances in Treatment with Dr Camran Nezhat
Endometriosis is a disease where the cells of internal lining of the uterus (endometrium) starts to grow outside the uterus, mainly on organs in the pelvis, causing a maze of symptoms including not only pelvic pain, infertility, and severe menstrual…
Breakthroughs in Reproductive Health: Leading the Way for Personalized Fertility Medicine
Over the last few decades, breakthrough advancements in the field of fertility has helped many infertile couples start a family successfully. Innovations like non-invasive tests that can identify genetic abnormalities and multi-gene panel tests have brought personalized medicine to reproductive…
Myeloma 2017 – Year in Review with MMRF
The MMRF is pioneering precision medicine initiatives in multiple myeloma. This would help match patients to the most effective therapies based on their genetics and other unique factors. buy ampicillin online https://rxxbuynoprescriptiononline.net/buy-ampicillin.html no prescription pharmacy buy bupropion online https://www.islington-chiropractic.co.uk/wp-content/uploads/2025/03/jpg/bupropion.html no…